What is the recommended oral dose of codeine for cough in a typical healthy adult, including dosing frequency and maximum daily amount?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Codeine for Cough in Adults: Dosing Recommendations

Codeine is NOT recommended for routine cough suppression in adults, particularly for acute viral upper respiratory infections, due to lack of efficacy over placebo and significant adverse effects; however, when used for chronic bronchitis, the typical dose is 10-20 mg orally every 4-6 hours, not exceeding 120 mg per day.

Key Clinical Context

The evidence reveals a critical disconnect between codeine's historical use and its actual efficacy:

When Codeine Should NOT Be Used

For acute viral cough/upper respiratory infections: Multiple Thorax guidelines explicitly state that "opiate antitussives have no greater efficacy than dextromethorphan but have a much greater adverse side effect profile and are not recommended" 1111. Research confirms codeine performs no better than placebo for acute URI-associated cough 23.

Limited Appropriate Use

For chronic bronchitis only: The ACCP guidelines support codeine use specifically for chronic bronchitis with "fair evidence, intermediate benefit" 4. Even here, the recommendation is qualified and limited to short-term symptomatic relief.

Specific Dosing When Prescribed

When codeine is deemed appropriate (chronic bronchitis), FDA labeling indicates 5:

  • Adults: 10 mg (2 teaspoons of 10 mg/5 mL formulation) every 4 hours
  • Maximum: 6 doses in 24 hours (60 mg/day maximum from this source)

Clinical practice data suggests 6:

  • Typical daily dose: 30 mg/day (range 21.6-30 mg)
  • Dosing interval: Every 4-6 hours as needed
  • Duration: Median 27.5 days in real-world practice, though 14% of patients receive it >8 weeks

Research studies have used 78:

  • 60 mg/day total (divided doses) for chronic cough evaluation

Critical Safety Considerations

Adverse effects are common and clinically significant:

  • Constipation and sedation are the most frequent side effects 97
  • 7.8% of patients report documented side effects in real-world practice 6
  • Drowsiness can impair daily function 11

Practical Algorithm

  1. Identify cough etiology first:

    • Acute viral URI → Do NOT use codeine; recommend dextromethorphan 60 mg or simple remedies (honey/lemon) 11
    • Chronic bronchitis → Codeine may be considered for short-term use
  2. If prescribing for chronic bronchitis:

    • Start: 10-15 mg every 4-6 hours
    • Maximum: 60-120 mg/day (do not exceed 6 doses/24 hours)
    • Duration: Limit to shortest effective period (typically <4 weeks)
  3. Monitor closely for:

    • Constipation (most common)
    • Sedation/drowsiness
    • Lack of efficacy (consider discontinuation if no improvement in 3-5 days)

Important Caveats

The evidence strongly suggests codeine is overused: Real-world data shows 54% of chronic cough patients receive codeine 6, despite research demonstrating it's no more effective than placebo for COPD-related cough 8 and acute URI cough 23. The ACCP guidelines specifically removed codeine from recommendations for URI-associated cough compared to prior versions 4.

Better alternatives exist: Dextromethorphan at 60 mg doses shows actual efficacy for acute cough with fewer side effects 11, while peripheral cough suppressants like levodropropizine are recommended for bronchitis with better tolerability 4.

Related Questions

When is codeine appropriate for treating cough in adults, including dosing, duration, and contraindications?
In a 77-year-old patient with a cold, acute COPD exacerbation, and nighttime cough who is already taking gabapentin, oxycodone, duloxetine, and baclofen, is Cheratussin AC (codeine 30 mg + guaifenesin 120 mg) a better option for cough suppression?
What are the prescribing options and guidelines for a codeine‑containing antitussive syrup in an adult patient?
What are the Pakistani trade names for a codeine‑based antitussive syrup combined with a first‑generation antihistamine?
Is it appropriate for an adult to use a codeine‑containing cough syrup for a severe non‑productive cough?
What is the recommended initial regimen, dosing, device technique, and follow‑up for starting a patient on low‑dose inhaled corticosteroids (e.g., budesonide) for asthma or COPD?
For a patient with COPD who continues to have dyspnea or frequent exacerbations despite a single long‑acting bronchodilator, or for a patient with asthma uncontrolled on low‑dose inhaled corticosteroid, which fixed‑dose LABA/LAMA (long‑acting β₂‑agonist/long‑acting muscarinic antagonist) inhaler combination is recommended, how should it be used, and what follow‑up is required?
How common is hyperostosis frontalis interna (HFI) in 70-year-old women?
What is the appropriate prescription for an adult with streptococcal infection who has a penicillin (PCN) allergy?
How long can a patient with ulcerative colitis go without medical treatment?
In a 28-year-old man with hip and knee pain and an anti‑streptolysin O (ASO) titer of 700 U/mL, could the elevated ASO be related to his joint symptoms?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.